Exlites Holdings International, Inc. (EXHI)
0.35
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Exlites Holdings International Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| October 31, 2023 | 0.00 |
| July 31, 2023 | 0.00 |
| April 30, 2023 | 0.00 |
| Date | Value |
|---|---|
| October 31, 2022 | |
| July 31, 2022 | |
| April 30, 2022 | 0.1166M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Xcelerate, Inc. | -- |
| Vivos Therapeutics, Inc. | -- |
| Hinge Health, Inc. | 34.06M |
| Anika Therapeutics, Inc. | 7.341M |
| Enovis Corp. | 31.69M |